Details
Stereochemistry | ACHIRAL |
Molecular Formula | C4H4FN3O |
Molecular Weight | 129.0925 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
NC1=NC(=O)NC=C1F
InChI
InChIKey=XRECTZIEBJDKEO-UHFFFAOYSA-N
InChI=1S/C4H4FN3O/c5-2-1-7-4(9)8-3(2)6/h1H,(H3,6,7,8,9)
Molecular Formula | C4H4FN3O |
Molecular Weight | 129.0925 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:02:47 UTC 2023
by
admin
on
Fri Dec 15 15:02:47 UTC 2023
|
Record UNII |
D83282DT06
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C1557
Created by
admin on Fri Dec 15 15:02:48 UTC 2023 , Edited by admin on Fri Dec 15 15:02:48 UTC 2023
|
||
|
WHO-ATC |
D01AE21
Created by
admin on Fri Dec 15 15:02:48 UTC 2023 , Edited by admin on Fri Dec 15 15:02:48 UTC 2023
|
||
|
WHO-ATC |
J02AX01
Created by
admin on Fri Dec 15 15:02:48 UTC 2023 , Edited by admin on Fri Dec 15 15:02:48 UTC 2023
|
||
|
EU-Orphan Drug |
EU/3/18/1978
Created by
admin on Fri Dec 15 15:02:48 UTC 2023 , Edited by admin on Fri Dec 15 15:02:48 UTC 2023
|
||
|
WHO-VATC |
QJ02AX01
Created by
admin on Fri Dec 15 15:02:48 UTC 2023 , Edited by admin on Fri Dec 15 15:02:48 UTC 2023
|
||
|
NDF-RT |
N0000175467
Created by
admin on Fri Dec 15 15:02:48 UTC 2023 , Edited by admin on Fri Dec 15 15:02:48 UTC 2023
|
||
|
NDF-RT |
N0000175459
Created by
admin on Fri Dec 15 15:02:48 UTC 2023 , Edited by admin on Fri Dec 15 15:02:48 UTC 2023
|
||
|
WHO-VATC |
QD01AE21
Created by
admin on Fri Dec 15 15:02:48 UTC 2023 , Edited by admin on Fri Dec 15 15:02:48 UTC 2023
|
||
|
NDF-RT |
N0000175459
Created by
admin on Fri Dec 15 15:02:48 UTC 2023 , Edited by admin on Fri Dec 15 15:02:48 UTC 2023
|
||
|
LIVERTOX |
NBK548624
Created by
admin on Fri Dec 15 15:02:48 UTC 2023 , Edited by admin on Fri Dec 15 15:02:48 UTC 2023
|
||
|
NDF-RT |
N0000175459
Created by
admin on Fri Dec 15 15:02:48 UTC 2023 , Edited by admin on Fri Dec 15 15:02:48 UTC 2023
|
||
|
FDA ORPHAN DRUG |
327910
Created by
admin on Fri Dec 15 15:02:48 UTC 2023 , Edited by admin on Fri Dec 15 15:02:48 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
6.3
Created by
admin on Fri Dec 15 15:02:48 UTC 2023 , Edited by admin on Fri Dec 15 15:02:48 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
D83282DT06
Created by
admin on Fri Dec 15 15:02:48 UTC 2023 , Edited by admin on Fri Dec 15 15:02:48 UTC 2023
|
PRIMARY | |||
|
FLUCYTOSINE
Created by
admin on Fri Dec 15 15:02:48 UTC 2023 , Edited by admin on Fri Dec 15 15:02:48 UTC 2023
|
PRIMARY | Description: A white or almost white, crystalline powder; odourless or almost odourless. Solubility: Sparingly soluble in water; slightly soluble in ethanol (~750 g/l) TS; practically insoluble in ether R. Category: Antifungal drug. Storage: Flucytosine should be kept in a tightly closed container, protected from light.Additional information: Flucytosine melts at about 295 ?C. Definition: Flucytosine contains not less than 98.5% and not more than 101.0% of C4H4FN3O, calculated with reference to the dried substance. | ||
|
5100
Created by
admin on Fri Dec 15 15:02:48 UTC 2023 , Edited by admin on Fri Dec 15 15:02:48 UTC 2023
|
PRIMARY | |||
|
103805
Created by
admin on Fri Dec 15 15:02:48 UTC 2023 , Edited by admin on Fri Dec 15 15:02:48 UTC 2023
|
PRIMARY | |||
|
1272000
Created by
admin on Fri Dec 15 15:02:48 UTC 2023 , Edited by admin on Fri Dec 15 15:02:48 UTC 2023
|
PRIMARY | |||
|
100000091594
Created by
admin on Fri Dec 15 15:02:48 UTC 2023 , Edited by admin on Fri Dec 15 15:02:48 UTC 2023
|
PRIMARY | |||
|
DB01099
Created by
admin on Fri Dec 15 15:02:48 UTC 2023 , Edited by admin on Fri Dec 15 15:02:48 UTC 2023
|
PRIMARY | |||
|
D83282DT06
Created by
admin on Fri Dec 15 15:02:48 UTC 2023 , Edited by admin on Fri Dec 15 15:02:48 UTC 2023
|
PRIMARY | |||
|
C501
Created by
admin on Fri Dec 15 15:02:48 UTC 2023 , Edited by admin on Fri Dec 15 15:02:48 UTC 2023
|
PRIMARY | |||
|
3366
Created by
admin on Fri Dec 15 15:02:48 UTC 2023 , Edited by admin on Fri Dec 15 15:02:48 UTC 2023
|
PRIMARY | |||
|
FLUCYTOSINE
Created by
admin on Fri Dec 15 15:02:48 UTC 2023 , Edited by admin on Fri Dec 15 15:02:48 UTC 2023
|
PRIMARY | |||
|
CHEMBL1463
Created by
admin on Fri Dec 15 15:02:48 UTC 2023 , Edited by admin on Fri Dec 15 15:02:48 UTC 2023
|
PRIMARY | |||
|
2022-85-7
Created by
admin on Fri Dec 15 15:02:48 UTC 2023 , Edited by admin on Fri Dec 15 15:02:48 UTC 2023
|
PRIMARY | |||
|
1188
Created by
admin on Fri Dec 15 15:02:48 UTC 2023 , Edited by admin on Fri Dec 15 15:02:48 UTC 2023
|
PRIMARY | |||
|
217-968-7
Created by
admin on Fri Dec 15 15:02:48 UTC 2023 , Edited by admin on Fri Dec 15 15:02:48 UTC 2023
|
PRIMARY | |||
|
DTXSID3023059
Created by
admin on Fri Dec 15 15:02:48 UTC 2023 , Edited by admin on Fri Dec 15 15:02:48 UTC 2023
|
PRIMARY | |||
|
m5426
Created by
admin on Fri Dec 15 15:02:48 UTC 2023 , Edited by admin on Fri Dec 15 15:02:48 UTC 2023
|
PRIMARY | Merck Index | ||
|
2729
Created by
admin on Fri Dec 15 15:02:48 UTC 2023 , Edited by admin on Fri Dec 15 15:02:48 UTC 2023
|
PRIMARY | |||
|
3082
Created by
admin on Fri Dec 15 15:02:48 UTC 2023 , Edited by admin on Fri Dec 15 15:02:48 UTC 2023
|
PRIMARY | |||
|
SUB07676MIG
Created by
admin on Fri Dec 15 15:02:48 UTC 2023 , Edited by admin on Fri Dec 15 15:02:48 UTC 2023
|
PRIMARY | |||
|
D005437
Created by
admin on Fri Dec 15 15:02:48 UTC 2023 , Edited by admin on Fri Dec 15 15:02:48 UTC 2023
|
PRIMARY | |||
|
4451
Created by
admin on Fri Dec 15 15:02:48 UTC 2023 , Edited by admin on Fri Dec 15 15:02:48 UTC 2023
|
PRIMARY | RxNorm |
Related Record | Type | Details | ||
---|---|---|---|---|
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (TITRATION)
EP
|
||
|
BINDER->LIGAND |
BINDING
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
For the calculation of contents, multiply the peak areas by 0.6
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
PARENT -> IMPURITY | |||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Volume of Distribution | PHARMACOKINETIC |
|
|
|||
Biological Half-life | PHARMACOKINETIC |
|
|
|||